If you're seeing this message, that means
JavaScript has been disabled on your browser
, please
enable JS
to make this app work.
No tags found
Companies
No companies found
Advanced Search
Newsfeed
Alerts
Saved Lists
Sign Up for Free
Login
Get Updates
8
Followers on Owler
Iterum Therapeutics
is an Ireland-based clinical-stage pharmaceutical company that develops and commercializes anti-infectives for the healthcare sector...
Read more
Overview
Competitors
Funding
News & Insights
Iterum Therapeutics
is an Ireland-based clinical-stage pharmaceutical company that develops and commercializes anti-infectives for the healthcare sector...
Read more
CEO
Corey N Fishman
CEO Approval Rating
97/100
Weigh In
2015
Dublin
County Dublin
Public
NASDAQ
ITRM
Pharmaceuticals & Biotechnology
Pharmaceuticals
Biotechnology
2834
2836
NAICS listing
https://www.iterumtx.com/
Annual Revenue
$ < 1M
Employees
9
Funding
$217.3M
News
Latest News
Apr 29, 2025
centralcharts
Press Release: Iterum Therapeutics : Iterum Therapeutics Announces $5 Million Registered Direct Offering of Ordinary Shares
Apr 14, 2025
Benzinga
Iterum Therapeutics: Iterum Therapeutics Presented a Scientific Poster at ECCMID 2025 Highlighting the Impact of Age on Antibiotic Resistance and Efficacy of Antibiotics
Feb 10, 2025
Owler
Iterum Therapeutics plc: Iterum Therapeutics's employee count changed from 14 in Feb 2024 to 9 in Dec 2024
Feb 07, 2025
Seeking Alpha
Iterum Therapeutics: Iterum Therapeutics plc (ITRM) Q4 2024 Earnings Call Transcript
Feb 07, 2025
Seeking Alpha
Iterum Therapeutics: Iterum outlines ORLYNVAH's market potential with exclusivity through 2034
Feb 07, 2025
Seeking Alpha
Iterum Therapeutics: Iterum Therapeutics Non-GAAP EPS of -$0.12 beats by $0.12
Feb 07, 2025
Marketscreener
Iterum Therapeutics: Iterum Therapeutics plc Reports Earnings Results for the Full Year Ended December 31, 2024
Nov 21, 2024
Seeking Alpha
Iterum Therapeutics: Iterum Therapeutics regains full Nasdaq compliance
Nov 14, 2024
Seeking Alpha
Iterum Therapeutics: Iterum Therapeutics Non-GAAP EPS of -$0.24 misses by $0.03
Nov 14, 2024
Seeking Alpha
Iterum Therapeutics: Iterum Therapeutics plc (ITRM) Q3 2024 Earnings Call Transcript
Follow and Get Alerts
Iterum Therapeutics Competitors
1
Follow
2
Follow
3
Follow
4
Follow
5
Follow
6
Follow
7
Follow
8
Follow
9
Follow
10
Follow
Unlock 24 + competitors
Trending Companies